Advertisement

Financially-troubled Angiotech Pharmaceuticals, Inc. says affected creditors have unanimously approved its revised restructuring plan. The company is scheduled to seek an order from the Supreme Court of British Columbia on Wednesday.

Advertisement
Advertisement